Full name
CLINICAL MEDICAL RESEARCH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
CLINICAL MEDICAL RESEARCH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. ALEJA WOJCIECHA KORFANTEGO 138, 40-156 KATOWICE
TAX ID6342857540
Rate company:
CLINICAL MEDICAL RESEARCH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID6342857540
KRS0000603688
Share capital205,000.00 zł
address
UL. ALEJA WOJCIECHA KORFANTEGO 138, 40-156 KATOWICE
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
6342857540
REGON
363813696
KRS
0000603688
Legal form
limited liability company
Register Address
UL. ALEJA WOJCIECHA KORFANTEGO 138, 40-156 KATOWICE
Date of registration in KRS
2016-02-25
Date of commencement of economic activity
2016-02-25
Act signature
KA.VIII NS-REJ.KRS/9611/19/995/ADE
Pkd codes
72.19.Z - Scientific research and development activities
70.22.Z - Head office activities and management consultancy
72.11.Z - Scientific research and development activities
72.20.Z - Scientific research and development in social sciences and humanities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
86.10.Z - Hospital activities
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.90.D - Healthcare
86.90.E - Healthcare
Payer VAT status
Active
Vat list bank account(s)
PL70 1050 1214 1000 0090 3087 0829 
PL71 1050 1214 1000 0090 3087 0811 PL48 1050 1214 1000 0090 3087 0837 Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0 | 0,6 | 0,5 | -22,7 |
EBITDA | 0,1 | 0,7 | 0,5 | -17,2 |
Short time liabilities | 0,6 | 0,7 | 0,6 | -17,1 |
Equity capital | 1,8 | 2,3 | 2,4 | 5,9 |
Operating profit (EBIT) | 0,1 | 0,7 | 0,5 | -17,2 |
Assets | 2,6 | 3 | 3 | 0,3 |
Net profit (loss) | 0 | 0,5 | 0,4 | -22,9 |
Cash | 1,2 | 1,5 | 1,8 | 22,8 |
Net income from sale | 2,4 | 3,4 | 4,8 | 43,1 |
Liabilities and provisions for liabilities | 0,8 | 0,7 | 0,6 | -17,1 |
Working assets | 2,1 | 2,9 | 2,9 | 0,4 |
Depreciation | 0 | 0 | 0 | -25,6 |
% | % | % | p.p. | |
Profitability of capital | 1,3 | 24,1 | 17,6 | -6,5 |
Equity capital to total assets | 71,1 | 75,4 | 79,7 | 4,3 |
Gross profit margin | 1,2 | 17,9 | 9,7 | -8,2 |
EBITDA Margin | 2,8 | 19,6 | 11,4 | -8,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 86 | 80 | 46 | -34 |
Current financial liquidity indicator | 3.6130006313323975 | 3.9604005813598633 | 4.794332981109619 | 0,8 |
Net dept to EBITDA | -9.069133758544922 | -1.4954700469970703 | -2.965379476547241 | -1,5 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.